{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:15:28Z","timestamp":1768810528304,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s40120-024-00590-0","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T13:02:53Z","timestamp":1709298173000},"page":"551-562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Constructing and Validating a Nomogram Model for Short-Term Prognosis of Patients with AChR-Ab+ GMG"],"prefix":"10.1007","volume":"13","author":[{"given":"Feng","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqian","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Make","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueli","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4434-5599","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"issue":"10","key":"590_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14(10):1023\u201336.","journal-title":"Lancet Neurol"},{"issue":"1","key":"590_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren J. Myasthenia gravis. Nat Rev Dis Primers. 2019;5(1):30.","journal-title":"Nat Rev Dis Primers"},{"key":"590_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2377-10-46","volume":"10","author":"AS Carr","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol. 2010;10:46.","journal-title":"BMC Neurol"},{"issue":"1","key":"590_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13023-023-02727-0","volume":"18","author":"M Mahic","year":"2023","unstructured":"Mahic M, Bozorg A, DeCourcy J, Golden K, Gibson G, Taylor C, et al. Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey. Orphanet J Rare Dis. 2023;18(1):169.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"590_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/CND.0000000000000034","volume":"15","author":"NJ Silvestri","year":"2014","unstructured":"Silvestri NJ, Wolfe GI. Treatment-refractory myasthenia gravis. J Clin Neuromuscul Dis. 2014;15(4):167\u201378.","journal-title":"J Clin Neuromuscul Dis"},{"issue":"4","key":"590_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","volume":"87","author":"DB Sanders","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016;87(4):419\u201325.","journal-title":"Neurology"},{"issue":"1","key":"590_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00439-011-1028-3","volume":"130","author":"K Offit","year":"2011","unstructured":"Offit K. Personalized medicine: new genomics, old lessons. Hum Genet. 2011;130(1):3\u201314.","journal-title":"Hum Genet"},{"issue":"1","key":"590_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018622","volume":"99","author":"Y Geng","year":"2020","unstructured":"Geng Y, Zhang H, Wang Y. Risk factors of myasthenia crisis after thymectomy among myasthenia gravis patients: a meta-analysis: erratum. Medicine. 2020;99(1): e18622.","journal-title":"Medicine"},{"issue":"1","key":"590_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.17712\/nsj.2021.1.20190041","volume":"26","author":"F Alqarni","year":"2021","unstructured":"Alqarni F, Almalki D, Aljohani Z, Ali A, AlSaleem A, Alotaibi N, et al. Prevalence and risk factors of myasthenia gravis recurrence post-thymectomy. Neurosciences (Riyadh, Saudi Arabia). 2021;26(1):4\u201314.","journal-title":"Neurosciences (Riyadh, Saudi Arabia)"},{"key":"590_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102895","volume":"132","author":"K Chen","year":"2022","unstructured":"Chen K, Li Y, Yang H. Poor responses and adverse outcomes of myasthenia gravis after thymectomy: predicting factors and immunological implications. J Autoimmun. 2022;132: 102895.","journal-title":"J Autoimmun"},{"issue":"1","key":"590_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12967-021-02961-9","volume":"19","author":"R Zhao","year":"2021","unstructured":"Zhao R, Wang Y, Huan X, Zhong H, Zhou Z, Xi J, et al. Nomogram for short-term outcome assessment in AChR subtype generalized myasthenia gravis. J Transl Med. 2021;19(1):285.","journal-title":"J Transl Med"},{"issue":"1","key":"590_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology. 2000;55(1):16\u201323.","journal-title":"Neurology"},{"issue":"1","key":"590_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/mus.27247","volume":"64","author":"Y Yoshimoto","year":"2021","unstructured":"Yoshimoto Y, Ishida S, Hosokawa T, Arawaka S. Assessment of clinical factors affecting outcome of myasthenia gravis. Muscle Nerve. 2021;64(1):90\u20134.","journal-title":"Muscle Nerve"},{"issue":"1","key":"590_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12974-022-02448-4","volume":"19","author":"C Nelke","year":"2022","unstructured":"Nelke C, Stascheit F, Eckert C, Pawlitzki M, Schroeter CB, Huntemann N, et al. Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients. J Neuroinflamm. 2022;19(1):89.","journal-title":"J Neuroinflamm"},{"key":"590_CR15","doi-asserted-by":"publisher","first-page":"175628642311549","DOI":"10.1177\/17562864231154976","volume":"16","author":"H Zhong","year":"2023","unstructured":"Zhong H, Ruan Z, Yan C, Lv Z, Zheng X, Goh LY, et al. Short-term outcome prediction for myasthenia gravis: an explainable machine learning model. Ther Adv Neurol Disord. 2023;16:17562864231154976.","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"590_CR16","first-page":"205","volume":"52","author":"E Ortona","year":"2016","unstructured":"Ortona E, Pierdominici M, Maselli A, Veroni C, Aloisi F, Shoenfeld Y. Sex-based differences in autoimmune diseases. Annali dell\u2019Istituto superiore di sanita. 2016;52(2):205\u201312.","journal-title":"Annali dell\u2019Istituto superiore di sanita"},{"issue":"1","key":"590_CR17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12883-023-03406-0","volume":"23","author":"H Wilcke","year":"2023","unstructured":"Wilcke H, Glaubitz S, K\u00fcck F, Anten C, Liebetanz D, Schmidt J, et al. Female sex and overweight are associated with a lower quality of life in patients with myasthenia gravis: a single center cohort study. BMC Neurol. 2023;23(1):366.","journal-title":"BMC Neurol"},{"issue":"5","key":"590_CR18","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/mus.23236","volume":"45","author":"HD Katzberg","year":"2012","unstructured":"Katzberg HD, Barnett C, Bril V. Predictors of response to immunomodulation in patients with myasthenia gravis. Muscle Nerve. 2012;45(5):648\u201352.","journal-title":"Muscle Nerve"},{"issue":"9","key":"590_CR19","first-page":"638","volume":"10","author":"PS Liberski","year":"2020","unstructured":"Liberski PS, Szewczyk M, Krzych \u0141J. Haemogram-derived indices for screening and prognostication in critically ill septic shock patients: a case-control study. Diagnostics (Basel, Switzerland). 2020;10(9):638.","journal-title":"Diagnostics (Basel, Switzerland)."},{"issue":"4","key":"590_CR20","first-page":"5937","volume":"8","author":"M Gunaldi","year":"2015","unstructured":"Gunaldi M, Goksu S, Erdem D, Gunduz S, Okuturlar Y, Tiken E, et al. Prognostic impact of platelet\/lymphocyte and neutrophil\/lymphocyte ratios in patients with gastric cancer: a multicenter study. Int J Clin Exp Med. 2015;8(4):5937\u201342.","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"590_CR21","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jvs.2013.08.095","volume":"59","author":"HJ Halazun","year":"2014","unstructured":"Halazun HJ, Mergeche JL, Mallon KA, Connolly ES, Heyer EJ. Neutrophil-lymphocyte ratio as a predictor of cognitive dysfunction in carotid endarterectomy patients. J Vasc Surg. 2014;59(3):768\u201373.","journal-title":"J Vasc Surg"},{"issue":"1","key":"590_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12883-021-02412-4","volume":"21","author":"CW Hsu","year":"2021","unstructured":"Hsu CW, Chen NC, Huang WC, Lin HC, Tsai WC, Huang CC, et al. Hemogram parameters can predict in-hospital mortality of patients with myasthenic crisis. BMC Neurol. 2021;21(1):388.","journal-title":"BMC Neurol"},{"issue":"44","key":"590_CR23","doi-asserted-by":"publisher","first-page":"76099","DOI":"10.18632\/oncotarget.18546","volume":"8","author":"DH Yang","year":"2017","unstructured":"Yang DH, Qian MZ, Wei MM, Li J, Yu MM, Lu XM, et al. The correlation of neutrophil-to-lymphocyte ratio with the presence and activity of myasthenia gravis. Oncotarget. 2017;8(44):76099\u2013107.","journal-title":"Oncotarget"},{"issue":"9","key":"590_CR24","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1080\/00207454.2020.1759592","volume":"131","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Ning Z, Yang L, Chen B, Tang J, Zhang J, et al. The correlation of neutrophil-to-lymphocyte ratio with the presence and short-time curative effect of myasthenia gravis in children: a retrospectively study. Int J Neurosci. 2021;131(9):894\u2013901.","journal-title":"Int J Neurosci"},{"key":"590_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jocn.2022.10.017","volume":"106","author":"Z Duan","year":"2022","unstructured":"Duan Z, Jia A, Cui W, Feng J. Correlation between neutrophil-to-lymphocyte ratio and severity of myasthenia gravis in adults: a retrospective study. J Clin Neurosci. 2022;106:117\u201321.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"590_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jocn.2012.05.020","volume":"20","author":"Z Hao","year":"2013","unstructured":"Hao Z, Wu B, Wang D, Lin S, Tao W, Liu M. A cohort study of patients with anemia on admission and fatality after acute ischemic stroke. J Clin Neurosci. 2013;20(1):37\u201342.","journal-title":"J Clin Neurosci"},{"issue":"3","key":"590_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/15412555.2011.647131","volume":"9","author":"C Martinez-Rivera","year":"2012","unstructured":"Martinez-Rivera C, Portillo K, Mu\u00f1oz-Ferrer A, Mart\u00ednez-Ortiz ML, Molins E, Serra P, et al. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD. 2012;9(3):243\u201350.","journal-title":"COPD"},{"issue":"9","key":"590_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0273720","volume":"17","author":"K Sekiguchi","year":"2022","unstructured":"Sekiguchi K, Ishizuchi K, Takizawa T, Motegi H, Oyama M, Nakahara J, et al. Anemia in female patients with myasthenia gravis. PLoS ONE. 2022;17(9): e0273720.","journal-title":"PLoS ONE"},{"key":"590_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.790941","volume":"12","author":"J Shi","year":"2021","unstructured":"Shi J, Huan X, Zhou L, Xi J, Song J, Wang Y, et al. Comorbid autoimmune diseases in patients with myasthenia gravis: a retrospective cross-sectional study of a Chinese cohort. Front Neurol. 2021;12: 790941.","journal-title":"Front Neurol"},{"issue":"5\u20136","key":"590_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000503961","volume":"81","author":"Z Lv","year":"2019","unstructured":"Lv Z, Zhong H, Huan X, Song J, Yan C, Zhou L, et al. predictive score for in-hospital mortality of myasthenic crisis: a retrospective Chinese cohort study. Eur Neurol. 2019;81(5\u20136):287\u201393.","journal-title":"Eur Neurol"},{"issue":"12","key":"590_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105405","volume":"29","author":"Y Yoshimura","year":"2020","unstructured":"Yoshimura Y, Wakabayashi H, Nagano F, Bise T, Shimazu S, Shiraishi A. Low hemoglobin levels are associated with sarcopenia, dysphagia, and adverse rehabilitation outcomes after stroke. J Stroke Cerebrovasc Dis. 2020;29(12): 105405.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"590_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.978997","volume":"13","author":"KH Kim","year":"2022","unstructured":"Kim KH, Kim SW, Cho J, Chung HY, Shin HY. Anti-titin antibody is associated with more frequent hospitalization to manage thymoma-associated myasthenia gravis. Front Neurol. 2022;13: 978997.","journal-title":"Front Neurol"},{"issue":"4","key":"590_CR33","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.nmd.2023.02.013","volume":"33","author":"YL Tang","year":"2023","unstructured":"Tang YL, Ruan Z, Su Y, Guo RJ, Gao T, Liu Y, et al. Clinical characteristics and prognosis of very late-onset myasthenia gravis in China. Neuromusc Disord NMD. 2023;33(4):358\u201366.","journal-title":"Neuromusc Disord NMD"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-024-00590-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-024-00590-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-024-00590-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T07:32:05Z","timestamp":1716967925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-024-00590-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["590"],"URL":"https:\/\/doi.org\/10.1007\/s40120-024-00590-0","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"assertion":[{"value":"13 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This research adhered to the ethical guidelines set forth in the Declaration of Helsinki and was approved by the ethical committee at The First Hospital of Shanxi Medical University (No. KYLL-2023-107). Due to the retrospective nature of the study, the requirement for written informed consent for the utilization of clinical data was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}